Clinical Trial Update: Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of IMVT-1402 in adults with moderate to severe systemic Primary Sjögren's disease is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• IMVT-1402

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Primary Sjögren's Syndrome | Phase 2 | Status: RECRUITING